CCL2 Kit ELISA

N° du produit ABIN577069

Détail du produit CCL2 Kit ELISA

Antigène: CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))

Reactivité: Humain

Méthode de détection: Colorimetric

Type de méthode: Sandwich ELISA

Gamme de detection: 4-1600 pg/mL

Seuil minimal de détection: 4 pg/mL

Application: ELISA

Fonction: This MCAF enzyme-linked immunosorbent assay (ELISA) applies a technique called a quantitative sandwich immunoassay. The microtiter plate provided in this kit has been pre-coated with a monoclonal antibody specific for MCAF. Standards or samples are then added - the appropriate microtiter plate wells and incubated. MCAF if present, will bind and become immobilized by the antibody pre-coated on the wells. The microtiter plate wells are thoroughly washed - remove unbound MCAF and other components of the sample. In order - quantify the amount of MCAF present in the sample, a standardized preparation of horseradish peroxidase (HRP)-conjugated polyclonal antibody specific for MCAF is added - each well to

Analytical Method: Quantitative

Sensibilité: < 4 pg/mL

Ingrédients: Standards: 1 set/2 vials

Information d'application

Plaque: Pre-coated

Restrictions: For Research Use only

Stockage

Agent conservateur: Without preservative

Détail du antigène

Antigène: CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))

Autre désignation: Monocyte Chemotactic Activating Factor (MCP-1/MCAF) (CCL2 Produits)

Synonymes: GDCF-2 Kit ELISA, HC11 Kit ELISA, HSMCR30 Kit ELISA, MCAF Kit ELISA, MCP-1 Kit ELISA, MCP1 Kit ELISA, SCYA2 Kit ELISA, SMC-CF Kit ELISA, AI323594 Kit ELISA, JE Kit ELISA, Scya2 Kit ELISA, Sigje Kit ELISA, MCP-1A Kit ELISA, MCP1A Kit ELISA, C-C motif chemokine ligand 2 Kit ELISA, chemokine (C-C motif) ligand 2 Kit ELISA, C-C motif chemokine 2 Kit ELISA, CCL2 Kit ELISA, Ccl2 Kit ELISA, LOC101120093 Kit ELISA

Sujet: Hepatitis resulting from infection with viruses other than Hepatitis A Virus (HAV) and Hepatitis B (HBV) virus was previously referred to as non-A, non-B hepatitis. The first characterised non-A, non-B hepatitis agent was that responsible for parentally transmitted non-A, non-B hepatitis, or what is now called Hepatitis C Virus. This was followed by the cloning of a portion of the fecal-orally-transmitted agent, the Hepatitis E Virus (HEV). Hepatitis E Virus has been referred to as enterically transmitted non-A, non-B hepatitis. Epidemics of enterically transmitted Hepatitis E Virus have been recognised worldwide but occur principally in developing countries. They have been reported in Southeast Asia, central Asia, Africa, Mexico, and Central America. In these areas, contaminated water has been implicated as the principal vehicle of virus transmission. Although HEV and HAV are transmitted in a similar manner, there are major differences in the clinical, pathological, and epidemiological courses of these two viruses. In particular, the mortality rate for HEV infection is 1 to 2%, or approximately 1-fold greater than that seen for HAV. Infection with HEV is particularly fatal for pregnant women, for whom the mortality rate can be as high as 1 to 2%

Pathways: Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, Phosphorylation & l'infection par le SRAS-CoV-2